Pharma Focus Asia
258 FOLLOWERS
Covers articles related to manufacturing, clinical trials, research and development, strategy, Information technology. Pharma Focus Asia, published by Ochre Media, is the leading pharma title in print and digital versions serving the information needs of key executives from the worlds leading pharmaceutical companies.
Pharma Focus Asia
6d ago
Boundless Bio a clinicalstage oncology company interrogating extrachromosomal DNA biology to deliver transformative therapies to patients with previously intractable oncogeneamplified cancers ..read more
Pharma Focus Asia
6d ago
SciSparc Ltd a specialty clinicalstage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system announced today that it signed a merger agreement with AutoMax Motors Ltd a leading vehicle importer company in Israel ..read more
Pharma Focus Asia
6d ago
Nanoform Finland Plc today announced a strategic partnership whereby CBC Co Ltd will utilize its extensive experience in the Japanese pharmaceutical industry to identify opportunities for Nanoforms ..read more
Pharma Focus Asia
6d ago
Mitsubishi Tanabe Pharma America Inc has announced that the US Food and Drug Administration has granted seven years of Orphan Drug Exclusivity for RADICAVA ORS This recognition is based on the FDAs ..read more
Pharma Focus Asia
6d ago
Phanes Therapeutics Inc a biotechnology company specializing in innovative oncology drug discovery and development announced today that the US Food and Drug Administration has granted Fast Track designation to PT for the treatment of patients with extensivestage small cell lung cancer ..read more
Pharma Focus Asia
6d ago
Mabwell an innovative biopharmaceutical company with a complete industry chain has announced that its whollyowned subsidiary Tmab has received marketing authorization approval from the National Medical ..read more
Pharma Focus Asia
6d ago
Teva Pharmaceuticals a subsidiary of Teva Pharmaceutical Industries Ltd has released findings from a Phase trial examining the effectiveness and safety of AJOVY in preventing migraines in adult Chinese ..read more
Pharma Focus Asia
2w ago
InnoCare Pharma a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase b clinical study of the combination of InnoCares ..read more
Pharma Focus Asia
2w ago
On March th the US FDA granted approval for Mercks WINREVAIR sotaterceptcsrk marking a significant milestone in pulmonary arterial hypertension PAH treatment PAH characterized by elevated blood pressure in the arteries connecting the heart and lungs poses a grave risk ..read more
Pharma Focus Asia
2w ago
GenFleet Therapeutics a pioneering clinicalstage biotech company focusing on innovative therapies ..read more